Testing effectiveness (Phase 2)Ended earlyNCT00792831
What this trial is testing
Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
Who this might be right for
Chronic Lymphocytic Leukemia
Italfarmaco 3